|
Children’s National is the nation’s No. 6 children’s hospital and, for the third year in a row, its neonatology program is No.1 among all children’s hospitals providing newborn intensive care, according to the U.S. News Best Children’s Hospitals annual rankings for 2019-20. This is also the ninth straight year that Children's National has ranked in all 10 specialty services, with five specialty service areas ranked among the top 10. |
|
|
A new pre-clinical study led by Matthew Oetgen, M.D., MBA, and Daniel Casella, M.D., will explore the use of anti-inflammatory medications to prevent the body’s inflammatory response from further damaging limbs after an injury restricts blood flow. Varenicline and cytisine, anti-inflammatories with similarities to nicotine, have shown early promise in similar pre-clinical laboratory studies. |
|
|
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announced five winners of its “Make Your Medical Device Pitch for Kids!” competition held on April 30 at the University of Maryland. The competition focused solely on advancing care in the pediatric orthopedics and spine sector which the FDA identified as an emerging underserved specialty lacking innovation. |
|
|
In April, Children’s National and Johnson & Johnson Innovation LLC announced a collaboration to launch JLABS @ Washington, DC, a 32,000-square foot facility that will be located at the new Children’s National Research & Innovation Campus. The new site will serve as an incubator for pharmaceutical, medical device, consumer and health technology companies. |
|
|
No hay comentarios:
Publicar un comentario